Psoriasis is a chronic inflammatory disease of the skin affecting approximately 2% of the
world's population. Systemic treatments, including methotrexate and cyclosporin, are …

Considered more efficacious and safer than traditional systemic drugs, biologic therapies
have dramatically improved the quality of life of patients with psoriasis. Recently, there has …

This consensus report includes expert opinions and recommendations regarding the
screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before …

Chronic hepatitis B virus (HBV) infection remains a serious global health concern. Cisplatin
is a chemotherapeutic agent commonly used to treat various cancers. However, HBV …

Abstract Background. Sub-Saharan African nations have among the highest rates of chronic
hepatitis B virus (HBV) infection worldwide, but little is known about HBV infection in African …

Hepatitis B virus (HBV) reactivation is a common complication of immunosuppressive
treatment in high prevalence countries. Biological disease-modifying antirheumatic drugs …

Objective The purpose of this study was to determine hepatitis B virus (HBV) screening rates
in patients receiving anti‐tumor necrosis factor (TNF)‐α therapy and the frequency of HBV …

Background Bruton tyrosine kinase inhibitors (BTKis) interrupt B-cell receptor signaling and
thereby could potentially reactivate hepatitis B virus (HBV). However, data about the risk for …

Background Reactivation of hepatitis B virus (HBV) is a fatal complication of chemotherapy.
Occult HBV infection might be reactivated in patients undergoing chemotherapy or …

Chronic hepatitis B virus infection (CHB) caused by the hepatitis B virus (HBV) is one of the
most common viral infections in the world. Reactivation of HBV infection is a life-threatening …